{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T23:32:32Z","timestamp":1793403152138,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s00210-026-05120-3","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T08:39:23Z","timestamp":1771576763000},"page":"11055-11071","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Natural compounds as immune checkpoint inhibitors in melanoma: a systematic review"],"prefix":"10.1007","volume":"399","author":[{"given":"Sajjad","family":"Samieefar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omid","family":"Arasteh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negar","family":"Yeganeh Khorasanii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farshad","family":"Abedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid Reza","family":"Hosseinzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Hosseinzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,20]]},"reference":[{"issue":"3","key":"5120_CR1","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","volume":"20","author":"AG Atanasov","year":"2021","unstructured":"Atanasov AG, Zotchev SB, Dirsch VM, Supuran CT (2021) Natural products in drug discovery: advances and opportunities. Nat Rev Drug Discov 20(3):200\u2013216","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"5120_CR2","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.bcp.2013.11.008","volume":"87","author":"HH Cao","year":"2014","unstructured":"Cao HH, Tse AKW, Kwan HY, Yu H, Cheng CY, Su T et al (2014) Quercetin exerts anti-melanoma activities and inhibits STAT3 signaling. Biochemical pharmacology. 87(3):424\u201334","journal-title":"Biochemical pharmacology."},{"key":"5120_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1470071","volume":"15","author":"Y Chen","year":"2024","unstructured":"Chen Y, Wang Z, Zhang C, Su Y, Zhou T, Hu K (2024) Revealing the mechanism of natural product-induced immunogenic cell death: opening a new chapter in tumor immunotherapy. Front Immunol 15:1470071","journal-title":"Front Immunol"},{"key":"5120_CR4","doi-asserted-by":"publisher","first-page":"153473542513193","DOI":"10.1177\/15347354251319339","volume":"24","author":"E Cho","year":"2025","unstructured":"Cho E, Yi J-M, Chun J, Jang H, Yoon SH, Lee SH et al (2025) Efficacy and safety of herbal medicine Bojungikki-Tang in combination with pembrolizumab versus pembrolizumab monotherapy for stage IV non-small cell lung cancer: study protocol for a randomized, open-label, double-arm, multicenter trial. Integr Cancer Ther 24:15347354251319340","journal-title":"Integr Cancer Ther"},{"issue":"1","key":"5120_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.phyplu.2024.100690","volume":"5","author":"J Choudhari","year":"2025","unstructured":"Choudhari J, Nimal SK, Chougule S, Shinde T, Dhatrak N, Kundu GC et al (2025) Mechanism of melanoma suppression by Prosopis juliflora derived alkaloids: apoptosis induction and signaling pathway inhibition. Phytomedicine plus 5(1):100690","journal-title":"Phytomedicine plus"},{"issue":"9","key":"5120_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/antiox13091030","volume":"13","author":"X Deng","year":"2024","unstructured":"Deng X, Yang Z, Chan KW, Ismail N, Abu Bakar MZ (2024a) 5-fluorouracil in combination with calcium carbonate nanoparticles loaded with antioxidant thymoquinone against colon cancer: synergistically therapeutic potential and underlying molecular mechanism. Antioxidants 13(9):1030","journal-title":"Antioxidants"},{"issue":"8","key":"5120_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16081011","volume":"16","author":"X Deng","year":"2024","unstructured":"Deng X, Yang Z, Chan KW, Abu Bakar MZ (2024b) Exploring the therapeutic potential of 5-fluorouracil-loaded calcium carbonate nanoparticles combined with natural compound thymoquinone for colon cancer treatment. Pharmaceutics 16(8):1011","journal-title":"Pharmaceutics"},{"issue":"7","key":"5120_CR8","doi-asserted-by":"publisher","DOI":"10.1088\/2053-1591\/adeb4c","volume":"12","author":"X Deng","year":"2025","unstructured":"Deng X, Zanna MY, Ahmed H, Ismail N, Chan KW, Esa NM et al (2025a) Recent progress in calcium carbonate nanoparticles for cancer therapy: design strategies and clinical prospects. Mater Res Express 12(7):072001","journal-title":"Mater Res Express"},{"issue":"1","key":"5120_CR9","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1002\/ptr.8378","volume":"39","author":"X Deng","year":"2025","unstructured":"Deng X, Yang Z, Han M, Ismail N, Esa NM, Razis AFA et al (2025b) Comprehensive insights into the combinatorial uses of selected phytochemicals in colorectal cancer prevention and treatment: isothiocyanates, quinones, carotenoids, and alkaloids. Phytother Res 39(1):413\u2013452","journal-title":"Phytother Res"},{"key":"5120_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.174726","volume":"916","author":"Q Gong","year":"2022","unstructured":"Gong Q, Yu H, Ding G, Ma J, Wang Y, Cheng X (2022) Suppression of stemness and enhancement of chemosensibility in the resistant melanoma were induced by Astragalus polysaccharide through PD-L1 downregulation. Eur J Pharmacol 916:174726","journal-title":"Eur J Pharmacol"},{"issue":"12","key":"5120_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/nu15122790","volume":"15","author":"N-R Han","year":"2023","unstructured":"Han N-R, Park H-J, Ko S-G, Moon P-D (2023) The mixture of natural products SH003 exerts anti-melanoma effects through the modulation of PD-L1 in B16F10 cells. Nutrients 15(12):2790","journal-title":"Nutrients"},{"issue":"12","key":"5120_CR12","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1002\/eji.201948225","volume":"49","author":"H Hao","year":"2019","unstructured":"Hao H, Zhang Q, Zhu H, Wen Y, Qiu D, Xiong J et al (2019) Icaritin promotes tumor T\u2010cell infiltration and induces antitumor immunity in mice. Eur J Immunol 49(12):2235\u20132244","journal-title":"Eur J Immunol"},{"key":"5120_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2016.00048","volume":"3","author":"Z Harris","year":"2016","unstructured":"Harris Z, Donovan MG, Branco GM, Limesand KH, Burd R (2016) Quercetin as an emerging anti-melanoma agent: a four-focus area therapeutic development strategy. Front Nutr 3:48","journal-title":"Front Nutr"},{"key":"5120_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.974896","volume":"9","author":"X Huang","year":"2022","unstructured":"Huang X, Wang Y, Yang W, Dong J, Li L (2022) Regulation of dietary polyphenols on cancer cell pyroptosis and the tumor immune microenvironment. Front Nutr 9:974896","journal-title":"Front Nutr"},{"issue":"1","key":"5120_CR15","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/6054706","volume":"2017","author":"S Ishikawa","year":"2017","unstructured":"Ishikawa S, Ishikawa T, Tezuka C, Asano K, Sunagawa M, Hisamitsu T (2017) Efficacy of juzentaihoto for tumor immunotherapy in B16 melanoma metastasis model. Evid Based Complement Alternat Med 2017(1):6054706","journal-title":"Evid Based Complement Alternat Med"},{"issue":"1","key":"5120_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-72697-1","volume":"14","author":"S Jafari","year":"2024","unstructured":"Jafari S, Ardakan AK, Aghdam EM, Mesbahi A, Montazersaheb S, Molavi O (2024) Induction of immunogenic cell death and enhancement of the radiation-induced immunogenicity by chrysin in melanoma cancer cells. Sci Rep 14(1):23231","journal-title":"Sci Rep"},{"key":"5120_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1149554","volume":"14","author":"P Kumar","year":"2023","unstructured":"Kumar P, Mangla B, Javed S, Ahsan W, Musyuni P, Sivadasan D et al (2023) A review of nanomaterials from synthetic and natural molecules for prospective breast cancer nanotherapy. Front Pharmacol 14:1149554","journal-title":"Front Pharmacol"},{"issue":"8","key":"5120_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/ph18081162","volume":"18","author":"M Kurkiewicz","year":"2025","unstructured":"Kurkiewicz M, Mo\u017adzierz A, Rzepecka-Stojko A, Stojko J (2025) Chrysin: a comprehensive review of its pharmacological properties and therapeutic potential. Pharmaceuticals 18(8):1162","journal-title":"Pharmaceuticals"},{"key":"5120_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.584959","volume":"11","author":"P Lasso","year":"2020","unstructured":"Lasso P, Gomez-Cadena A, Urue\u00f1a C, Donda A, Martinez-Usatorre A, Romero P et al (2020) An immunomodulatory gallotanin-rich fraction from Caesalpinia spinosa enhances the therapeutic effect of anti-PD-L1 in melanoma. Front Immunol 11:584959","journal-title":"Front Immunol"},{"key":"5120_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.111000","volume":"124","author":"X Li","year":"2023","unstructured":"Li X, He L, Ou Y, Wang S, Hu Y, Niu H (2023) Oxymatrine inhibits melanoma development by modulating the immune microenvironment and targeting the MYC\/PD-L1 pathway. Int Immunopharmacol 124:111000","journal-title":"Int Immunopharmacol"},{"key":"5120_CR21","unstructured":"Li X, Li Y, Chen S, Guo L, Mei N (2025a) Potential anticancer effects and toxicity of flavones luteolin and apigenin in vivo.\u00a0J Environ Sci Health, Part C 1\u201337"},{"issue":"1","key":"5120_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-91137-2","volume":"15","author":"J Li","year":"2025","unstructured":"Li J, Jiang L, Ma Q, Zhang Z, Zheng S, Qiu J et al (2025b) Evodiamine inhibits programmed cell death ligand 1 expression via the PI3K\/AKT signaling pathway to regulate antitumor immunity in melanoma. Sci Rep 15(1):6649","journal-title":"Sci Rep"},{"issue":"12","key":"5120_CR23","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1016\/j.apsb.2020.06.014","volume":"10","author":"Y Liu","year":"2020","unstructured":"Liu Y, Liu X, Zhang N, Yin M, Dong J, Zeng Q et al (2020) Berberine diminishes cancer cell PD-L1 expression and facilitates antitumor immunity via inhibiting the deubiquitination activity of CSN5. Acta Pharm Sin B 10(12):2299\u20132312","journal-title":"Acta Pharm Sin B"},{"issue":"11","key":"5120_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25112692","volume":"25","author":"F Mainini","year":"2020","unstructured":"Mainini F, Eccles MR (2020) Lipid and polymer-based nanoparticle siRNA delivery systems for cancer therapy. Molecules 25(11):31","journal-title":"Molecules"},{"issue":"11","key":"5120_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-024-03825-z","volume":"73","author":"J Malhotra","year":"2024","unstructured":"Malhotra J, De S, Nguyen K, Lee P, Villaflor V (2024) Genomic and molecular alterations associated with primary resistance to immune checkpoint inhibitors. Cancer Immunol Immunother 73(11):234","journal-title":"Cancer Immunol Immunother"},{"issue":"10","key":"5120_CR26","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1124\/dmd.120.000085","volume":"48","author":"V Mohos","year":"2020","unstructured":"Mohos V, Flisz\u00e1r-Ny\u00fal E, Ungv\u00e1ri O, Bakos \u00c9, Kuffa K, Bencsik T et al (2020) Effects of chrysin and its major conjugated metabolites chrysin-7-sulfate and chrysin-7-glucuronide on cytochrome P450 enzymes and on OATP, P-gp, BCRP, and MRP2 transporters. Drug Metab Dispos 48(10):1064\u20131073","journal-title":"Drug Metab Dispos"},{"key":"5120_CR27","volume":"27","author":"CP Mungwari","year":"2025","unstructured":"Mungwari CP, King\u2019ondu CK, Sigauke P, Obadele BA (2025) Conventional and modern techniques for bioactive compounds recovery from plants. Sci Afr 27:e02509","journal-title":"Sci Afr"},{"issue":"22","key":"5120_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222212549","volume":"22","author":"NW Nkune","year":"2021","unstructured":"Nkune NW, Abrahamse H (2021) Nanoparticle-based drug delivery systems for photodynamic therapy of metastatic melanoma: a review. Int J Mol Sci 22(22):12549","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5120_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-021-02282-3","volume":"21","author":"Z Nozhat","year":"2021","unstructured":"Nozhat Z, Heydarzadeh S, Memariani Z, Ahmadi A (2021) Chemoprotective and chemosensitizing effects of apigenin on cancer therapy. Cancer Cell Int 21(1):574","journal-title":"Cancer Cell Int"},{"issue":"24","key":"5120_CR30","doi-asserted-by":"publisher","first-page":"35518","DOI":"10.1007\/s11356-022-19423-4","volume":"29","author":"S Pai","year":"2022","unstructured":"Pai S, Hebbar A, Selvaraj S (2022) A critical look at challenges and future scopes of bioactive compounds and their incorporations in the food, energy, and pharmaceutical sector. Environ Sci Pollut Res Int 29(24):35518\u201335541","journal-title":"Environ Sci Pollut Res Int"},{"issue":"2","key":"5120_CR31","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1056\/NEJMra1703481","volume":"378","author":"MA Postow","year":"2018","unstructured":"Postow MA, Sidlow R, Hellmann MD (2018) Immune-related adverse events associated with immune checkpoint blockade. N Engl J Med 378(2):158\u2013168","journal-title":"N Engl J Med"},{"issue":"11","key":"5120_CR32","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.3390\/ph14111081","volume":"14","author":"D Ravindran Menon","year":"2021","unstructured":"Ravindran Menon D, Li Y, Yamauchi T, Osborne DG, Vaddi PK, Wempe MF et al (2021) EGCG inhibits tumor growth in melanoma by targeting JAK-STAT signaling and its downstream PD-L1\/PD-L2-PD1 axis in tumors and enhancing cytotoxic T-cell responses. Pharmaceuticals 14(11):1081","journal-title":"Pharmaceuticals"},{"issue":"8","key":"5120_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/molecules23082071","volume":"23","author":"A Rawangkan","year":"2018","unstructured":"Rawangkan A, Wongsirisin P, Namiki K, Iida K, Kobayashi Y, Shimizu Y et al (2018) Green tea catechin is an alternative immune checkpoint inhibitor that inhibits PD-L1 expression and lung tumor growth. Molecules 23(8):2071","journal-title":"Molecules"},{"issue":"9","key":"5120_CR34","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/S1470-2045(19)30388-2","volume":"20","author":"C Robert","year":"2019","unstructured":"Robert C, Ribas A, Schachter J, Arance A, Grob J-J, Mortier L et al (2019) Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study. Lancet Oncol 20(9):1239\u20131251","journal-title":"Lancet Oncol"},{"key":"5120_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fddsv.2022.1032587","volume":"2","author":"GR Sartori","year":"2022","unstructured":"Sartori GR, Albuquerque AdO, Santos-Costa AH, Andrade LM, Almeida DdS, Gaieta EM et al (2022) In silico mapping of the dynamic interactions and structure-activity relationship of flavonoid compounds against the immune checkpoint programmed-cell death 1 pathway. Frontiers in Drug Discovery 2:1032587","journal-title":"Frontiers in Drug Discovery"},{"key":"5120_CR36","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.cbi.2017.11.022","volume":"283","author":"A Sassi","year":"2018","unstructured":"Sassi A, Maatouk M, Bz\u00e9ouich IM, Hatira SAB, Jemni-Yacoub S, Ghedira K et al (2018) Chrysin, a natural and biologically active flavonoid suppresses tumor growth of mouse B16F10 melanoma cells: in vitro and in vivo study. Chemico-biological interactions. 283:10\u20139","journal-title":"Chemico-biological interactions."},{"issue":"6","key":"5120_CR37","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1211\/jpp.61.06.0015","volume":"61","author":"J Sathiavelu","year":"2009","unstructured":"Sathiavelu J, Senapathy GJ, Devaraj R, Namasivayam N (2009) Hepatoprotective effect of chrysin on prooxidant-antioxidant status during ethanol-induced toxicity in female albino rats. J Pharm Pharmacol 61(6):809\u2013817","journal-title":"J Pharm Pharmacol"},{"key":"5120_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.114025","volume":"177","author":"J Schomberg","year":"2020","unstructured":"Schomberg J, Wang Z, Farhat A, Guo KL, Xie J, Zhou Z et al (2020) Luteolin inhibits melanoma growth in vitro and in vivo via regulating ECM and oncogenic pathways but not ROS. Biochem Pharmacol 177:114025","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"5120_CR39","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.taap.2013.09.021","volume":"273","author":"T Singh","year":"2013","unstructured":"Singh T, Katiyar SK (2013) Green tea polyphenol,(\u2212)-epigallocatechin-3-gallate, induces toxicity in human skin cancer cells by targeting \u03b2-catenin signaling. Toxicol Appl Pharmacol 273(2):418\u2013424","journal-title":"Toxicol Appl Pharmacol"},{"issue":"5","key":"5120_CR40","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.jaccao.2022.09.004","volume":"4","author":"S Tan","year":"2022","unstructured":"Tan S, Day D, Nicholls SJ, Segelov E (2022) Immune checkpoint inhibitor therapy in oncology: current uses and future directions: JACC: CardioOncology state-of-the-art review. JACC CardioOncol 4(5):579\u2013597","journal-title":"JACC CardioOncol"},{"key":"5120_CR41","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S457643","author":"H Tang","year":"2024","unstructured":"Tang H, Dong L, Xia X, Chen X, Ren M, Shu G et al (2024) Preparation, optimization, and anti-pulmonary infection activity of casein-based chrysin nanoparticles. Int J Nanomedicine. https:\/\/doi.org\/10.2147\/IJN.S457643","journal-title":"Int J Nanomedicine"},{"key":"5120_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2024.158442","volume":"503","author":"Y Wang","year":"2025","unstructured":"Wang Y, Zang L, Guan L, Ren X, Xia Z, Li Z et al (2025a) Designed tumor microenvironment-remodeling bispolyphenol nanoparticles combined with \u03b1PD-L1 for enhanced melanoma immunotherapy. Chem Eng J 503:158442","journal-title":"Chem Eng J"},{"issue":"6","key":"5120_CR43","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.70144","volume":"86","author":"Rr Wang","year":"2025","unstructured":"Wang Rr, Wu H, Feng Ml, Zhong Jl, Li Rx, Zhou Bx (2025b) Berberine as a multi\u2010targeted therapeutic agent in melanoma: mechanisms, efficacy, and combination therapies. Drug Dev Res 86(6):e70144","journal-title":"Drug Dev Res"},{"issue":"23","key":"5120_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24234246","volume":"24","author":"Q-Y Wei","year":"2019","unstructured":"Wei Q-Y, He K-M, Chen J-L, Xu Y-M, Lau AT (2019) Phytofabrication of nanoparticles as novel drugs for anticancer applications. Molecules 24(23):4246","journal-title":"Molecules"},{"issue":"1","key":"5120_CR45","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s13046-018-0929-6","volume":"37","author":"L Xu","year":"2018","unstructured":"Xu L, Zhang Y, Tian K, Chen X, Zhang R, Mu X et al (2018) Apigenin suppresses PD-L1 expression in melanoma and host dendritic cells to elicit synergistic therapeutic effects. J Exp Clin Cancer Res 37(1):261","journal-title":"J Exp Clin Cancer Res"},{"issue":"10","key":"5120_CR46","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1038\/s41565-024-01722-1","volume":"19","author":"J Xu","year":"2024","unstructured":"Xu J, Yu Y, Zhang Y, Dai H, Yang Q, Wang B et al (2024) Oral administration of garlic-derived nanoparticles improves cancer immunotherapy by inducing intestinal IFN\u03b3-producing \u03b3\u03b4 T cells. Nat Nanotechnol 19(10):1569\u20131578","journal-title":"Nat Nanotechnol"},{"issue":"3","key":"5120_CR47","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1177\/1534735418766403","volume":"17","author":"M Yanaki","year":"2018","unstructured":"Yanaki M, Kobayashi M, Aruga A, Nomura M, Ozaki M (2018) In vivo antitumor effects of MK615 led by PD-L1 downregulation. Integr Cancer Ther 17(3):646\u2013653","journal-title":"Integr Cancer Ther"},{"key":"5120_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.fbio.2024.104511","volume":"60","author":"Z Yang","year":"2024","unstructured":"Yang Z, Deng X, Yang Z, Han M, Ismail N, Chan KW et al (2024) Polygonum minus: a tropical medicinal herb with vast applications in food, agricultural, and medicinal fields. Food Biosci 60:104511","journal-title":"Food Biosci"},{"issue":"5","key":"5120_CR49","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1080\/87559129.2024.2446366","volume":"41","author":"Z Yang","year":"2025","unstructured":"Yang Z, Cespedes-Acu\u00f1a CL, Yang Z, Abu Bakar MZ, Chan KW, Deng X (2025) Plant foods and their bioactives as dietary enhancers for colon cancer treatment with 5-fluorouracil. Food Rev Int 41(5):1390\u20131439","journal-title":"Food Rev Int"},{"issue":"8","key":"5120_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25084423","volume":"25","author":"YE Yoon","year":"2024","unstructured":"Yoon YE, Jung YJ, Lee S-J (2024) The anticancer activities of natural terpenoids that inhibit both melanoma and non-melanoma skin cancers. Int J Mol Sci 25(8):4423","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5120_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-12788-4","volume":"24","author":"H Yu","year":"2024","unstructured":"Yu H, Ding G, Gong Q, Ma J, Zhao Y, Wang Y et al (2024) Modulation of PD-L1 by Astragalus polysaccharide attenuates the induction of melanoma stem cell properties and overcomes immune evasion. BMC Cancer 24(1):1034","journal-title":"BMC Cancer"},{"issue":"42","key":"5120_CR52","doi-asserted-by":"publisher","first-page":"404","DOI":"10.4103\/0973-1296.153096","volume":"11","author":"X-A Zhang","year":"2015","unstructured":"Zhang X-A, Zhang S, Yin Q, Zhang J (2015) Quercetin induces human colon cancer cells apoptosis by inhibiting the nuclear factor-kappa B pathway. Pharmacogn Mag 11(42):404","journal-title":"Pharmacogn Mag"},{"issue":"3","key":"5120_CR53","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1002\/med.21876","volume":"42","author":"Z Zhong","year":"2022","unstructured":"Zhong Z, Vong CT, Chen F, Tan H, Zhang C, Wang N et al (2022) Immunomodulatory potential of natural products from herbal medicines as immune checkpoints inhibitors: helping to fight against cancer via multiple targets. Med Res Rev 42(3):1246\u20131279","journal-title":"Med Res Rev"},{"key":"5120_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1127071","volume":"14","author":"K Zhou","year":"2023","unstructured":"Zhou K, Li S, Zhao Y, Cheng K (2023) Mechanisms of drug resistance to immune checkpoint inhibitors in non-small cell lung cancer. Front Immunol 14:1127071","journal-title":"Front Immunol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05120-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05120-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05120-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T09:04:39Z","timestamp":1781514279000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05120-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,20]]},"references-count":54,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["5120"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05120-3","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,20]]},"assertion":[{"value":"14 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}